This inventor holds 3 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Andhra Pradesh, IN (2016)
- Hyderabad, IN (2016 - 2019)
Company Filing History:

Years Active: 2016-2019
Title: Veerender Murki: Innovator in Pharmaceutical Chemistry
Introduction
Veerender Murki is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and processes. With a total of 3 patents to his name, Murki continues to push the boundaries of innovation in drug formulation.
Latest Patents
Murki's latest patents include a co-crystal of carfilzomib with maleic acid and a process for the preparation of pure carfilzomib. This application focuses on the co-crystal formation, detailing the methods for preparing both the co-crystal and the amorphous form of carfilzomib. Additionally, he has developed processes for the preparation of bendamustine and its pharmaceutically acceptable salts, showcasing his expertise in creating effective pharmaceutical compounds.
Career Highlights
Veerender Murki is currently employed at Dr. Reddy's Laboratories, Incorporated, a leading global pharmaceutical company. His work at Dr. Reddy's has allowed him to collaborate with other talented professionals in the industry, further enhancing his contributions to pharmaceutical innovation.
Collaborations
Some of Murki's notable coworkers include Vilas Hareshwar Dahanukar and Goverdhan Gilla. Their collaborative efforts have played a crucial role in advancing the research and development initiatives at Dr. Reddy's Laboratories.
Conclusion
Veerender Murki stands out as an influential inventor in the pharmaceutical sector, with a focus on innovative drug formulations. His contributions, particularly in the area of co-crystals and bendamustine preparation, highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile